Vaccitech Overview
- Founded
- 2016

- Status
- Private
- Employees
- 43

- Latest Deal Type
- Early Stage VC
- Latest Deal Amount
- $13.4M

- Investors
- 13
Vaccitech General Information
Description
Developer of therapeutic vaccine technology designed to provide treatment for seasonal flu and prostate cancer. The company's technology includes live-attenuated, killed whole-cell and subunit antigen vaccines that deliver either one or two heterologous viral vector vaccines, each encoding the same antigen, enabling healthcare professionals to prevent influenza and treat prostate cancer and improve the protection provided by the seasonal flu vaccination.
Contact Information
- The Schrodinger Building, Heatley Road
- The Oxford Science Park
- Oxford OX4 4GE
- England, United Kingdom
Vaccitech Timeline
Vaccitech Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Early Stage VC | 26-Dec-2020 | $13.4M | 000.00 | Completed | Clinical Trials - General | |
5. Grant | 27-Aug-2020 | 00000 | 000.00 | Completed | Clinical Trials - General | |
4. Grant | 07-Mar-2019 | 00.00 | 000.00 | Completed | Clinical Trials - General | |
3. Early Stage VC (Series A) | 20-Dec-2018 | 00.000 | 000.00 | 000.00 | Completed | Clinical Trials - General |
2. Early Stage VC (Series A) | 14-Jan-2018 | $27M | $41.5M | 000.00 | Completed | Clinical Trials - General |
1. Seed Round | 10-May-2016 | $14.6M | $14.6M | 000.00 | Completed | Clinical Trials - General |
Vaccitech Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A | 0,000 | 00.000000 | 00000.00 | 00000.00 | 00 | 00000.00 | 0.000 | |
Series A | 00,000 | 00.000000 | 00000.00 | 00000.00 | 00 | 00000.00 | 00.000 | |
Ordinary | 13,333 | $0.012718 | $953.81 | $953.81 | 1x | $953.81 | 29.28% | |
Ordinary | 133 | $0.012718 | $956.2 | $956.2 | 1x | $956.2 | 0.29% |
Vaccitech Comparisons
Industry
00000000
000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialVaccitech Competitors (35)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Turnstone Biologics | Venture Capital-Backed | Ottawa, Canada | 00 | 00000 | 000000000000 | 00000 |
000000 | Venture Capital-Backed | Seattle, WA | 00 | 000.00 | 0000000000 0 | 000.00 |
000 0000000000000 | Formerly VC-backed | Princeton, NJ | 00 | 00.000 | 000000 - 000 | 00.000 |
00000000 000000000 | Venture Capital-Backed | Uppsala, Sweden | 00 | 0000000000 | ||
000000 00000000000 | Corporation | Cambridge, MA | 000 | 00000 | 000000 - 000 | 00000 |
Vaccitech Executive Team (10)
Vaccitech Board Members (8)
Name | Representing | Role | Since |
---|---|---|---|
Alex Hammacher | Self | Board Member | 000 0000 |
Andrew McLean MD | Oxford Sciences Innovation | Board Member | 000 0000 |
Pierre Morgon | Self | Board Member | 000 0000 |
Robin Wright | Self | Chairman | 000 0000 |
Thomas Evans MD | Vaccitech | Chief Scientific Officer, Board Member & CMO | 000 0000 |
Vaccitech Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialVaccitech Investors (13)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Future Planet Capital | Growth/Expansion | Minority | 000 0000 | 000000 0 | |
UK Research and Innovation | Government | 000 0000 | 000000 0 | ||
Biomedical Advanced Research and Development Authority | Corporation | 000 0000 | 000000 0 | ||
Genematrix | Corporation | Minority | 000 0000 | 000000 0 | |
Korea Investment Partners | Venture Capital | Minority | 000 0000 | 000000 0 |